The company’s digital health solution, Simoa, is changing the way in which the biology of health and disease is studied by giving researchers the ability to closely examine critical biomarkers. In doing so, Quanterix enables development of methods to provide much earlier disease detection, better prognoses and enhanced treatment methods and improve the quality of life and longevity of the population for generations to come. The technology is currently being used for applications in a majority of therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease.
Products & Technology
Simoa by the Numbers
Number of Scientific Publications
Number of Simoa Assays
Average Simoa LoD (fg/mL)
Average Simoa LoQ (fg/mL)
Enabling Insights Into The Biology of Health and Disease
Our digital health solution, Simoa, gives researchers the ability to closely examine critical biomarkers in the majority of therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease.
Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy
Tauopathies are a group of disorders in which the cytosolic protein tau aggregates and accumulates…
Type I interferons (IFNs) are essential mediators of antiviral responses. These cytokines have been…
Tauopathies are characterized by the progressive accumulation of hyperphosphorylated, aggregated…
The results from these 2 independent cohort studies suggest that serum NFL is a highly sensitive…